MOSCOW (Sputnik) – Hungarian Human Resources Minister Miklos Kasler said on Sunday that the national healthcare service centre had fully approved Russia’s Sputnik V vaccine against COVID-19 for use in the European country.
Apart from Sputnik V, three other vaccines have been approved for use in Hungary, namely the vaccines developed by Pfizer/BioNTech, Moderna and AstraZeneca.
On Tuesday, peer-reviewed medical journal The Lancet published an interim analysis from the phase 3 trial of the Sputnik V vaccine, showing its 91.6 percent efficacy against symptomatic COVID-19. It has been in 21 countries across the world.
The Russian Direct Investment Fund (RDIF), responsible for marketing the vaccine abroad, has initiated the process to get Sputnik V approved in the EU. So far, Hungary remains the only member of the bloc to have authorized the use of the Russian vaccine.